<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - FDA Promises Review of Pfizer’s COVID-19 Vaccine by October
Image Overlay - FDA Promises Review of Pfizer’s COVID-19 Vaccine by October

FDA Promises Review of Pfizer’s COVID-19 Vaccine by October

August 31, 2020

FDA Promises Review of Pfizer’s COVID-19 Vaccine by October

The FDA has promised to review Pfizer’s coronavirus vaccine before the November election, as early as this October. Nicholas Kitchin, M.D., a senior director in Pfizer's vaccine R&D group, told the Centers for Disease Control that the clinical trial of the company’s BioNTech-partnered COVID vaccine, BNT162b2, is more than 50% enrolled. A premium clinical supplies courier, Yourway helps crucial vaccine supplies reach their destinations around the world to facilitate faster trials.

Back to Index
Media

Upcoming Events

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Media

Articles

Case study: Coordinating a complex intercontinental shipment on a short timeline

Open chat
Come chat with us!
Hello! How can I help you?